|1.||Piomelli, Daniele: 2 articles (10/2012 - 08/2011)|
|2.||Desroches, J: 2 articles (11/2008 - 03/2007)|
|3.||Beaulieu, P: 2 articles (11/2008 - 03/2007)|
|4.||Guindon, J: 2 articles (11/2008 - 03/2007)|
|5.||Charron, Sophie: 1 article (02/2014)|
|6.||Beaulieu, Pierre: 1 article (02/2014)|
|7.||Bouchard, Jean-François: 1 article (02/2014)|
|8.||Desroches, Julie: 1 article (02/2014)|
|9.||Alvarez, Antonia: 1 article (10/2012)|
|10.||Girelli, Silvia: 1 article (10/2012)|
|1.||Neuralgia (Stump Neuralgia)
02/01/2014 - "Several recent studies examining the contribution of CB₁ and/or CB₂ receptors on the peripheral antinociceptive effects of AEA, 2-AG, URB597 and URB602 in neuropathic pain conditions using either pharmacological tools or transgenic mice separately have been reported, but the exact mechanism is still uncertain. "
11/01/2008 - "However, the anti-nociceptive effects of the combination of peripherally injected 2-AG, URB602 and URB597 in a neuropathic pain model have not yet been determined. "
|3.||Brain Injuries (Brain Injury)
10/01/2012 - "Pretreatment with the monoacylglycerol lipase inhibitor URB602 protects from the long-term consequences of neonatal hypoxic-ischemic brain injury in rats."
10/01/2012 - "These results demonstrate that a pretreatment with URB602 significantly reduces brain damage and improves functional outcome, indicating that endocannabinoid-degrading enzymes may represent an important target for neuroprotection in neonatal ischemic brain injury."
10/01/2012 - "This study was undertaken to assess whether preventing the deactivation of the endocannabinoid 2-arachidonoylglycerol (2-AG) with the monoacylglycerol lipase (MAGL) inhibitor URB602 can provide neuroprotective effects in hypoxia-ischemia (HI)-induced brain injury. "
03/01/2007 - "Locally injected 2-AG and URB602 decreased pain behaviour in a dose-dependent manner in an inflammatory model of pain. "
03/01/2007 - "The peripheral antinociceptive effects of 2-AG and URB602 in an inflammatory model of pain are not yet determined. "
11/01/2007 - "On these bases, URB602, a MAGL inhibitor, was tested in a murine model of inflammation/inflammatory pain. "
08/01/2011 - "KEY RESULTS Intra-paw administration of JZL184, URB602 and 2-AG suppressed early and late phases of formalin pain. "
|1.||cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)
|2.||Lipase (Acid Lipase)